Candriam S.C.A. - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 162 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2021$3,108,000
-4.0%
298,4920.0%0.03%0.0%
Q4 2020$3,236,000
+3.5%
298,492
-1.7%
0.03%
-10.3%
Q3 2020$3,127,000
-34.5%
303,575
+32.8%
0.03%
-42.0%
Q2 2020$4,773,000
+111.9%
228,575
+14.3%
0.05%
+100.0%
Q1 2020$2,252,000
-2.3%
200,0000.0%0.02%0.0%
Q4 2019$2,304,000200,0000.02%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders